author-photo

Onder Alpdogan

Thomas Jefferson University Hospital

4

Papers

0

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Oral Nanatinostat (Nstat) and Valganciclovir (VGCV) in Patients with Recurrent Epstein-Barr Virus (EBV)-Positive Lymphomas: Initial Phase 2 Results

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Results of a Phase I/II Study of Bendamustine in Combination with Ofatumumab, Carboplatin and Etoposide (BOCE) for Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)